# BXP, Inc.

> BXP is a publicly traded U.S. real estate investment trust that develops, owns, leases and manages office and life sciences properties. Its strategy concentrates on well-located, amenity-rich workplaces in six gateway markets, combining development and property operations with building-efficiency upgrades and institutional joint ventures.

- **Founded:** 1970
- **Headquarters:** Boston, United States
- **Founders:** Mortimer B. Zuckerman (Co-founder of predecessor business), Edward H. Linde (Co-founder of predecessor business)
- **Products:** Office leasing and property operations, Development and redevelopment, Life sciences properties, 343 Madison Avenue, Building energy improvements
- **Notable:** 164 properties and 51.1 million square feet including unconsolidated joint ventures as of June 30, 2026., Executed 106 leases totaling approximately 1.8 million square feet in Q2 2026., Reported 38% lower energy intensity in 2025 relative to its 2008 baseline.

## Products & services

- **Office leasing and property operations** — Office space, building management and tenant services across six U.S. gateway markets.
- **Development and redevelopment** — Acquisition, design, construction, leasing and repositioning of commercial properties.
- **Life sciences properties** — Specialized research and laboratory facilities, including 290 Binney Street, fully placed in service in 2026 and leased to AstraZeneca.
- **343 Madison Avenue** — A planned 46-story, approximately 930,000-square-foot Manhattan office tower with direct Grand Central access; expected completion in Q3 2029 as stated in October 2026.
- **Building energy improvements** — Efficiency projects, retro-commissioning, heat recovery and energy procurement integrated into property operations.

## Achievements

- 164 properties and 51.1 million square feet including unconsolidated joint ventures as of June 30, 2026.
- Executed 106 leases totaling approximately 1.8 million square feet in Q2 2026.
- Reported 38% lower energy intensity in 2025 relative to its 2008 baseline.
- Reported carbon-neutral operations for Scope 1 and 2 emissions as of December 31, 2025; this is not a claim of zero lifecycle emissions.
- DOE’s 2026 Better Project recognition described a heat recovery pilot at 601 Lexington Avenue with annual steam use reduced by more than 30%.

## Latest updates

- **2026-04** — Released the 2025 Sustainability & Impact Report, reporting efficiency improvements and Scope 1 and 2 carbon-neutral operations.
- **2026-06** — Announced an approximately 320,000-square-foot Boston Dynamics lease at Reservoir Place; phased relocation expected from mid-2027.
- **2026-07** — Reported Q2 revenue of $895.7 million and closed a $1.2 billion construction loan for 343 Madison Avenue.
- **2026-08** — Announced pricing of $700 million of 6.050% senior unsecured notes due 2036 through its operating partnership.
- **2026-10** — Closed the sale of a 10.6% equity interest in 343 Madison Avenue to AVRS Partners. The approximately $2 billion project was 56% pre-leased and expected to complete in Q3 2029.

## Links

- Website: https://www.bxp.com/
- LinkedIn: https://www.linkedin.com/company/bxp-inc
- Twitter/X: https://twitter.com/BXP_NYC
- Instagram: https://www.instagram.com/bxp_inc/
- Facebook: https://facebook.com/BXPSF/

---

Profile page: https://yespress.io/bxp-inc
Published by YesPress — https://yespress.io
Last updated: 2026-10-24